Dark Forest Capital Management LP Ibere Pharmaceuticals Transaction History

Dark Forest Capital Management LP

$520 Million
Q2 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$0.11 - $9.94 $664 - $60,027	-6,039 Reduced 27.94%	15,574 $154,000
Q2 2022 Aug 15, 2022	SELL	$9.77 - $9.84 $223,058 - $224,657	-22,831 Reduced 51.37%	21,613 $212,000
Q1 2022 May 13, 2022	SELL	$9.69 - $9.81 $506,748 - $513,023	-52,296 Reduced 54.06%	44,444 $436,000
Q4 2021 Feb 11, 2022	BUY	$9.68 - $9.77 $503,621 - $508,303	52,027 Added 116.36%	96,740 $940,000
Q3 2021 Nov 12, 2021	BUY	$9.61 - $9.78 $429,691 - $437,293	44,713 New	44,713 $433,000

Others Institutions Holding IBER

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About IBERE PHARMACEUTICALS

Ticker IBER
Exchange NYSE
Sector Financial Services
Industry Shell Companies
Shares Outstandng 13,800,000
Description
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.

More about IBER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.